Market Share of Global Oncolytic Virotherapy Industry
The mounting rise in the cases of cancer around the globe has created a buzz among companies to invest in the advancement of technologies for treatment. The rising number of pipeline candidates and intense market penetration of the drugs have made oncolytic virotherapy a pioneer in the therapeutic field which leads the significant competition in the market. Some of the prominent market leaders in the global oncolytic virus therapy market are Amgen Inc., Shanghai Sunway Biotech Co., Ltd., TILT Biotherapeutics Ltd., and Oncorus, Inc., Takara Bio Inc., Vyriad, Transgene SA, Lokon Pharma AB, Pfizer Inc., and others.
Oncolytic Virotherapy Market Leaders
-
Transgene SA
-
Sorrento Therapeutics, Inc.
-
Amgen
-
CG Oncology Inc
-
Oncolys BioPharma
*Disclaimer: Major Players sorted in no particular order
